Mechanism of tumour vascularization in experimental lung metastases

Journal of Pathology

Volumn 235, Issue 3, 2015, Pages 384-396

  Szabo, Vanessza ^a   Bugyik, Edina ^a   Dezso, Katalin ^a   Ecker, Nora ^a   Nagy, Peter ^a   Timar, Jozsef ^a,b   Tovari, Jozsef ^c   Laszlo, Viktoria ^d   Bridgeman, Victoria L ^e   Wan, Elaine ^e   Frentzas, Sophia ^e   Vermeulen, Peter B ^e,f   Reynolds, Andrew R ^e   Dome, Balazs ^c,d,g   Paku, Sandor ^a,b,h  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f SINT AUGUSTINUS HOSPITAL   (Belgium)

^g NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^h SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Angiogenesis; Arterialization; Lung metastasis; Vessel co option

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG ALVEOLUS WALL; LUNG CAPILLARY; LUNG METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION; ANIMAL; BLOOD VESSEL; BRONCHUS; C57BL MOUSE; COLON TUMOR; DISEASE MODEL; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; FIBROSARCOMA; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; SECONDARY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; BRONCHI; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; FIBROSARCOMA; HUMANS; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PNEUMOCYTES; RATS;

EID: 84920772286     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4464     Document Type: Article

References (54)

1. Krishnan K, Khanna C, Helman LJ. The molecular biology of pulmonary metastasis. Thorac Surg Clin 2006; 16: 115-124.
2. Snyder BJ, Pugatch RD. Imaging characteristics of metastatic disease to the chest. Chest Surg Clin N Am 1998; 8: 29-48.
3. Davis SD. CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology 1991; 180: 1-12.
4. Crow J, Slavin G, Kreel L. Pulmonary metastasis: a pathologic and radiologic study. Cancer 1981; 47: 2595-2602.
5. Schweiger T, Lang G, Klepetko W, et al. Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers. Eur J Cardiothorac Surg 2014; 45: 408-416.
6. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113: 37-49.
7. Bar J, Herbst RS, Onn A. Targeted drug delivery strategies to treat lung metastasis. Expert Opin Drug Deliv 2009; 6: 1003-1016.
8. Zheng Y, Fernando HC. Surgical and nonresectional therapies for pulmonary metastasis. Surg Clin North Am 2010; 90: 1041-1051.
9. Vogl TJ, Shafinaderi M, Zangos S, et al. Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors. Semin Intervent Radiol 2013; 30: 176-184.
10. Dome B, Hendrix MJ, Paku S, et al. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 2007; 170: 1-15.
11. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nature Rev Cancer 2006; 6: 583-592.
12. Moreno Garcia V, Basu B, Molife LR, et al. Combining antiangiogenics to overcome resistance: rationale and clinical experience. Clin Cancer Res 2012; 18: 3750-3761.
13. Mountzios G, Pentheroudakis G, Carmeliet P. Bevacizumab and micrometastases: revisiting the preclinical and clinical rollercoaster. Pharmacol Ther 2014; 141: 117-124.
14. Ebos JM, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nature Rev Clin Oncol 2011; 8: 210-221.
15. Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis 2014; 17: 471-494.
16. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
17. Folkman J.What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
18. Folkman J, Merler E, Abernathy C, et al. Isolation of a tumor factor responsible for angiogenesis. J ExpMed 1971; 133: 275-288.
19. Pezzella F, Pastorino U, Tagliabue E, et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1997; 151: 1417-1423.
20. Pezzella F, Di Bacco A, Andreola S, et al. Angiogenesis in primary lung cancer and lung secondaries. Eur J Cancer 1996; 32A: 2494-2500.
21. Adighibe O, Micklem K, Campo L, et al. Is nonangiogenesis a novel pathway for cancer progression?Astudy using 3-dimensional tumour reconstructions. Br J Cancer 2006; 94: 1176-1179.
22. Breast Cancer Progression Working Party. Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Lancet 2000; 355: 1787-1788.
23. Yousem SA. Peripheral squamous cell carcinoma of lung: patterns of growth with particular focus on airspace filling. Hum Pathol 2009; 40: 861-867.
24. Sardari Nia P, Hendriks J, Friedel G, et al. Distinct angiogenic and non-angiogenic growth patterns of lung metastases from renal cell carcinoma. Histopathology 2007; 51: 354-361.
25. Donnem T, Hu J, Ferguson M, et al. Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? Cancer Med 2013; 2: 427-436.
26. Mitzner W, Lee W, Georgakopoulos D, et al. Angiogenesis in the mouse lung. Am J Pathol 2000; 157: 93-101.
27. Verloop MC. On the arteriae bronchiales and their anastomosing with the arteria pulmonalis in some rodents; a micro-anatomical study. Acta Anat (Basel) 1949; 7: 1-32.
28. Dezso K, Bugyik E, Papp V, et al. Development of arterial blood supply in experimental liver metastases. Am J Pathol 2009; 175: 835-843.
29. Hanahan D,Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
30. Dome B, Timar J, Paku S. A novel concept of glomeruloid body formation in experimental cerebral metastases. J Neuropathol Exp Neurol 2003; 62: 655-661.
31. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155: 739-752.
32. Paku S, Dezso K, Bugyik E, et al. A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sprouting. Am J Pathol 2011; 179: 1573-1585.
33. Dome B, Timar J, Ladanyi A, et al. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: from biology to therapy. Crit Rev Oncol Hematol 2009; 69: 108-124.
34. Dome B, Paku S, Somlai B, et al. Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. J Pathol 2002; 197: 355-362.
35. Tanaka F, Oyanagi H, Takenaka K, et al. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer. Cancer Res 2003; 63: 6791-6794.
36. Wu S, Yu L, Wang D, et al. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer 2012; 12: 535.
37. Burri PH, Tarek MR. A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat Rec 1990; 228: 35-45.
38. Caduff JH, Fischer LC, Burri PH. Scanning electron microscope study of the developing microvasculature in the postnatal rat lung. Anat Rec 1986; 216: 154-164.
39. Ackermann M, Houdek JP, Gibney BC, et al. Sprouting and intussusceptive angiogenesis in postpneumonectomy lung growth: mechanisms of alveolar neovascularization. Angiogenesis 2014; 17: 541-551.
40. Low FN. Extracellular components of the pulmonary alveolar wall. Arch Intern Med 1971; 127: 847-852.
41. Rosario EJ, Lewis CW, Gureenberg SD, et al. The architecture of the alveolar wall: an ultrastructural study in man. Cardiovasc Res Cent Bull 1973; 12: 13-20.
42. Erber R, Thurnher A, Katsen AD, et al. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 2004; 18: 338-340.
43. Paku S, Kopper L, Nagy P. Development of the vasculature in 'pushing-type' liver metastases of an experimental colorectal cancer. Int J Cancer 2005; 115: 893-902.
44. Hayek Hv. The Human Lung. Hafner Pub Co: New York, 1960.
45. Schraufnagel DE, Pearse DB, Mitzner WA, et al. Three-dimensional structure of the bronchial microcirculation in sheep. Anat Rec 1995; 243: 357-366.
46. Giaccia AJ. Hypoxic stress proteins: survival of the fittest. Semin Radiat Oncol 1996; 6: 46-58.
47. Siemann DW, Keng PC. Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (II). Cell sorting. Br J Cancer 1988; 58: 296-300.
48. Tannock IF. The relation between cell proliferation and the vascular system in a transplanted mousemammary tumour. Br J Cancer 1968; 22: 258-273.
49. Mallick R, Demmy T. Regional lung chemotherapy techniques. Innovations (Phila) 2011; 6: 1-9.
50. Knierim M, Paku S, Paweletz N, et al. Ultrastructural studies on the lung colonization by nonmetastatic rat tumor cells. Anticancer Res 1986; 6: 669-682.
51. Lapis K, Paku S, Liotta LA. Endothelialization of embolized tumor cells during metastasis formation. Clin Exp Metastasis 1988; 6: 73-89.
52. Paku S, Dome B, Toth R, et al. Organ-specificity of the extravasation process: an ultrastructural study. Clin Exp Metastasis 2000; 18: 481-492.
53. Paku S, Paweletz N, Spiess E, et al. Ultrastructural analysis of experimentally induced invasion in the rat lung by tumor cells metastasizing lymphatically. Anticancer Res 1986; 6: 957-966.
54. Machado EA, Gerard DA,Mitchell JR, et al. Arrest and extravasation of neoplastic cells. An electron microscopy study of serial sections at sequential stages. Virchows Arch A Pathol Anat Histol 1982; 396: 73-89.